Similar Search Results

Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019

Momtazmanesh, Sara; Moghaddam, Sahar Saeedi; Ghamari, … - In: eClinicalMedicine 59 (2023), pp. 101936-101936

Persistent link: https://www.econbiz.de/10014315225

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Ong, Kanyin Liane; Stafford, Lauryn K.; McLaughlin, Susan A. - In: The Lancet 402 (2023), pp. 203-234

Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced...

Persistent link: https://www.econbiz.de/10014502358

Health care as an investment : implications for an era of ageing populations

Connolly, Mark P.; Postma, Maarten J. - In: Journal of medical marketing : device, diagnostic and … 10 (2010) 1, pp. 5-14

Persistent link: https://www.econbiz.de/10003951850

The effect of financial and educational incentives on rational prescribing : a state-space approach

Pechlivanoglou, Petros; Wieringa, Jaap E.; Jager, Tim de; … - In: Health economics 24 (2015) 4, pp. 439-453

Persistent link: https://www.econbiz.de/10011317738

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

Hagendijk, Marije E.; Schans, Simon van der; Boersma, … - In: The European journal of health economics 22 (2021) 6, pp. 991-999

Persistent link: https://www.econbiz.de/10012586745

Sustainability of public finances : inclusion of unrelated medical cost only part of the story

Connolly, Mark P.; Kotsopoulos, Nikolaos; Bhatt, Aomesh; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 8, pp. 1281-1282

Persistent link: https://www.econbiz.de/10012221345

Economic evaluation of meningococcal vaccines : considerations for the future

Christensen, Hannah; Al-Janabi, Hareth; Lévy, Pierre; … - In: The European journal of health economics : HEPAC ; … 21 (2020) 2, pp. 297-309

Persistent link: https://www.econbiz.de/10012221975

Cost-effectiveness of controlling gestational diabetes mellitus : a systematic review

Fitria, Najmiatul; Asselt, Antoinette D. I. van; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 3, pp. 407-417

Persistent link: https://www.econbiz.de/10012004957

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation

Jacobs, Maartje S.; Jong, Lisa A. de; Postma, Maarten J.; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 7, pp. 957-965

Persistent link: https://www.econbiz.de/10011947477

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands

Eijsink, Job F. H.; Al Khayat, Mohamed N. M. T.; … - In: The European journal of health economics 22 (2021) 1, pp. 75-88

Persistent link: https://www.econbiz.de/10012433947